|
Influenza, inactivated vaccine (IIV)
|
Severe allergic reaction (e.g., anaphylaxis) after previous dose of any influenza vaccine or to a vaccine component, including egg protein.
|
Moderate or severe acute illness with or without fever.
History of Guillain-Barré Syndrome (GBS) within 6 weeks of previous influenza vaccination.
Persons who experience only hives with exposure to eggs should receive IIV with additional safety precautions.2
|
|
Influenza, live attenuated (LAIV)3
|
Severe allergic reaction (e.g., anaphylaxis) after previous dose of any influenza vaccine or to a vaccine component, including egg protein.
Conditions for which the Advisory Committee on Immunization Practices (ACIP) recommends against use, but which are not contraindications in vaccine package insert: immune suppression, certain chronic medical conditions such as asthma, diabetes, heart or kidney disease. and pregnancy.4
|
Moderate or severe acute illness with or without fever.
History of GBS within 6 weeks of previous influenza vaccination.
Receipt of specific antivirals (i.e., amantadine, rimantadine, zanamivir, or oseltamivir) 48 hours before vaccination. Avoid use of these antiviral drugs for 14 days after vaccination.
|
ShareCompartir